Cipla launches anti-malaria drug for young children Industry-The Economic Times — July 25, 2017 comments off The company introduced 100 mg Artesunate Rectocaps/Rectal Artesunate Suppositories (RAS), a life-saving, pre-referral intervention for the management of malaria in children.
